• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Trials

PuraCap Pharmaceuticals Chooses StayinFront for Its Sales Force Automation Solution
FAIRFIELD, NJ--(Marketwired - Jun 17, 2013) - PuraCap Pharmaceuticals, an emerging, global pharmaceutical company headquartered in South Plainfield, New Jersey, has selected StayinFront Inc., as...(more)
StayinFront  
Jun 17, 2013 18:28 ET
 

 

Nuvo Research(R) and Paladin Labs Announce Amendment to May 2012 Loan Arrangement
MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO--(Marketwired - June 17, 2013) - Paladin Labs Inc. (TSX:PLB), a leading specialty pharmaceutical company and Nuvo Research Inc. (TSX:NRI), a...(more)
Nuvo Research Inc.   Paladin Labs Inc.  
Jun 17, 2013 17:00 ET
 

 

Nuvo Research et Laboratoires Paladin annoncent des modifications à la convention de prêt de mai 2012
MONTRÉAL, QUÉBEC et MISSISSAUGA, ONTARIO--(Marketwired - 17 juin 2013) - Laboratoires Paladin Inc. (TSX:PLB), société pharmaceutique spécialisée de premier plan et Nuvo Research Inc...(more)
Laboratoires Paladin Inc.   Nuvo Research Inc.  
Jun 17, 2013 17:00 ET
 

 

American Diabetes Association Announces Award Winners at 73rd Scientific Sessions
ALEXANDRIA, VA--(Marketwired - Jun 17, 2013) - The American Diabetes Association, the nation's leading voluntary health organization in the fight to Stop Diabetes®, is proud to announce this...(more)
American Diabetes Association  
Jun 17, 2013 12:43 ET
 

 

VistaGen Therapeutics Presents CardioSafe 3D(TM) and LiverSafe 3D(TM) Developments at International Society of Stem Cell Research's 11th Annual Meeting
SOUTH SAN FRANCISCO, CA--(Marketwired - Jun 17, 2013) - VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology...(more)
VistaGen Therapeutics, Inc.  
Jun 17, 2013 10:28 ET
 

 

New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and Younger
MARSEILLE, FRANCE--(Marketwired - Jun 17, 2013) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced...(more)
Edwards Lifesciences  
Jun 17, 2013 09:15 ET
 

 

Aragon Pharmaceuticals Announces Acquisition by Johnson & Johnson
SAN DIEGO, CA--(Marketwired - Jun 17, 2013) - Aragon Pharmaceuticals Inc., a leader in developing drugs for hormone driven cancers, today announced a definitive agreement with Johnson & Johnson...(more)
Aragon Pharmaceuticals  
Jun 17, 2013 08:00 ET
 

 

Genetic Technologies Provides U.S. Gene Patenting Update
MELBOURNE, AUSTRALIA--(Marketwired - Jun 17, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) provides an update to the Market on its position following the U.S. Supreme Court's...(more)
Genetic Technologies  
Jun 17, 2013 08:00 ET
 

 

Cellceutix Reports Kevetrin(TM) Dosing Increases and Prurisol(TM) Anti-Psoriasis Drug Stability Tests Underway
BEVERLY, MA--(Marketwired - Jun 17, 2013) - Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat...(more)
Cellceutix  
Jun 17, 2013 07:00 ET
 

 

Versartis Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting
SAN FRANCISCO, CA--(Marketwired - Jun 16, 2013) - Versartis, Inc. today presented the first results from its pediatric clinical trial of VRS-317, the company's proprietary long-acting form of...(more)
Versartis  
Jun 16, 2013 16:45 ET